Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
EDQM
0
USP
0
JP
0
Others
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
1. Echinomycin
2. Nsc 526417
3. Nsc-526417
4. Nsc526417
1. Echinomycin
2. Tg824j6rqt
3. 512-64-1
4. S-426-s (lepetit)
5. Nsc-526417
6. N,n'-((1r,4s,7r,11s,14r,17s,20r,24s)-11,24-diisopropyl-2,4,12,15,17,25-hexamethyl-27-(methylthio)-3,6,10,13,16,19,23,26-octaoxo-9,22-dioxa-28-thia-2,5,12,15,18,25-hexaazabicyclo[12.12.3]nonacosane-7,20-diyl)bis(quinoxaline-2-carboxamide)
7. Unii-tg824j6rqt
8. Nsc-13502
9. Sk 302b
10. Nsc 526417
11. Brn 0078671
12. Echinomycin [mi]
13. Antibiotic A-654i
14. 4-27-00-09726 (beilstein Handbook Reference)
15. Chembl503868
16. Schembl13464701
17. Sk-302b
18. Db15582
19. Stereoisomer Of N,n'-(2,4,12,15,17,25-hexamethyl-11,24-bis(1-methylethyl)-27-(methylthio)-3,6,10,13,16,19,23,26-octaoxo-9,22-dioxa-28-thia-2,5,12,15,18,25-hexaazabicyclo(12.12.3)nonacosane-7,20-diyl)bis(2-quinoxalinecarboxamide)
20. Hy-106101
21. Cs-0024860
22. L-valine, N-(2-quinoxalinylcarbonyl)-o-(n-(2-quinoxalinylcarbonyl)-d-seryl-l-alanyl-3-mercapto-n,s-dimethylcysteinyl-n-methyl-l-valyl)-d-seryl-l-alanyl-n-methylcysteinyl-n-methyl-, (8->1)-lactone, Cyclic (3->7)-thioether
23. N-(2-quinoxalinylcarbonyl)-o-(n-(2-quinoxalinylcarbonyl)-d-seryl-l-alanyl-3-mercapto-n,s-dimethylcysteinyl-n-methyl-l-valyl)-d-seryl-l-alanyl-n-methylcysteinyl-n-methyl L-valine (8->1)-lactone Cyclic (3->7)-thioester
| Molecular Weight | 1101.3 g/mol |
|---|---|
| Molecular Formula | C51H64N12O12S2 |
| XLogP3 | 2.7 |
| Hydrogen Bond Donor Count | 4 |
| Hydrogen Bond Acceptor Count | 18 |
| Rotatable Bond Count | 7 |
| Exact Mass | 1100.42080787 g/mol |
| Monoisotopic Mass | 1100.42080787 g/mol |
| Topological Polar Surface Area | 352 Ų |
| Heavy Atom Count | 77 |
| Formal Charge | 0 |
| Complexity | 2200 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 8 |
| Undefined Atom Stereocenter Count | 1 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
Anti-Bacterial Agents
Substances that inhibit the growth or reproduction of BACTERIA. (See all compounds classified as Anti-Bacterial Agents.)
Antibiotics, Antineoplastic
Chemical substances, produced by microorganisms, inhibiting or preventing the proliferation of neoplasms. (See all compounds classified as Antibiotics, Antineoplastic.)
Nucleic Acid Synthesis Inhibitors
Compounds that inhibit cell production of DNA or RNA. (See all compounds classified as Nucleic Acid Synthesis Inhibitors.)
ABOUT THIS PAGE
24
PharmaCompass offers a list of Echinomycin API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Echinomycin manufacturer or Echinomycin supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Echinomycin manufacturer or Echinomycin supplier.
PharmaCompass also assists you with knowing the Echinomycin API Price utilized in the formulation of products. Echinomycin API Price is not always fixed or binding as the Echinomycin Price is obtained through a variety of data sources. The Echinomycin Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Echinomycin manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Echinomycin, including repackagers and relabelers. The FDA regulates Echinomycin manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Echinomycin API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Echinomycin supplier is an individual or a company that provides Echinomycin active pharmaceutical ingredient (API) or Echinomycin finished formulations upon request. The Echinomycin suppliers may include Echinomycin API manufacturers, exporters, distributors and traders.
Echinomycin Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Echinomycin GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Echinomycin GMP manufacturer or Echinomycin GMP API supplier for your needs.
A Echinomycin CoA (Certificate of Analysis) is a formal document that attests to Echinomycin's compliance with Echinomycin specifications and serves as a tool for batch-level quality control.
Echinomycin CoA mostly includes findings from lab analyses of a specific batch. For each Echinomycin CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Echinomycin may be tested according to a variety of international standards, such as European Pharmacopoeia (Echinomycin EP), Echinomycin JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Echinomycin USP).
